Aller au contenu Aller au menu

Clarity and confidence

in EBV+ PTLD Care

PTLDhub, your trusted resource for EBV+ PTLD.

Designed to support healthcare professionals in navigating the complexities of EBV+ PTLD – an aggressive, life-threatening and challenging disease.1-4

Explore evidence-based information on disease biology, diagnosis and management strategies – including the latest insights into emerging treatments such as adoptive
T-cell immunotherapy.1,2,5

Care with confidence in EBV+ PTLD.

Swirl image
Understanding EBV+ PTLD

Explore how EBV biology and immune dysfunction drive PTLD after transplant

Learn more
Diagnosis & Monitoring

Identify the key signs, symptoms and diagnostic steps in PTLD

Learn more
Patient Management & Outcomes

See how treatment pathways and evolving strategies are supporting better outcomes

Learn more

Patient Website

A dedicated website for patients is also available.

Feel free to share it with your patients if they wish to better understand their condition and access numerous resources on PTLD.

GO TO PTLDinfo

Understanding 
Post-Transplant 
Lymphoproliferative 
Disease

PTLDinfo

Your feedback matters

Select below on a scale from 0–10:

How likely are you to recommend this website to a colleague?
Unlikely
Highly Likely
How likely are you to incorporate the learnings from this website into your clinical practice?
Unlikely
Highly Likely
References
  1. Dierickx D, Habermann TM. N Engl J Med. 2018;378(6):549–62. 
  2. Shahid S, Prockop SE. Cancer Drug Resist. 2021;4(3):646–64. 
  3. Fujimoto A, Suzuki R. Cancers (Basel). 2020;12(2):328. 
  4. Nijland ML, et al. Transplant Direct. 2015;2(1):e48. 
  5. Canichella M, de Fabritiis P. Antibodies (Basel). 2025;14(2):47. 
Abbreviations
  • EBV(+), Epstein–Barr virus (positive) 
  • PTLD, post-transplant lymphoproliferative disorder